Sponsored Online Access

Multiple Sclerosis Journal

As a special benefit for all our 2017 PACTRIMS delegates, PACTRIMS-sponsored online access to the Multiple Sclerosis Journal (MSJ) will be made available for a period of 1 year from 1st January 2018 to 1st January 2019. Delegates will be able to access the most recent content published between the January 2017 issue to the January 2019 issue; this includes key articles types such as Original Research papers, Controversies in MS and Topical Reviews.

2017 PACTRIMS delegates can request for a sponsored online access to the MSJ by replying to secretariat@pactrims.org by 25 November 2017 after registering for the Congress. Access credentials for the Journal will be sent to delegates by email after the Congress.

By requesting for this sponsored access, delegates consent to provide their name and email contact to SAGE Publications.

msj coverMultiple Sclerosis Journal (MSJ) is the sole official journal of PACTRIMS, ACTRIMS, ECTRIMS and LACTRIMS.

It is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. 

The journal for your research in the following areas:

♦ Biologic basis: pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics

♦ Epidemology and genetics: genetics epigenetics, epidemiology

♦ Clinical and Neuroimaging: clinical neurology, biomarkers, neuroimaging and clinical outcome measures

♦ Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management

Outstanding information presented in a topical based format. This journal is a member of the Committee on Publication Ethics (COPE). 

 

*Subject to change